Israel Englander Protalix Bio Therapeutics, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 373,757 shares of PLX stock, worth $646,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
373,757
Previous 811,160
53.92%
Holding current value
$646,599
Previous $949,000
59.85%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PLX
# of Institutions
50Shares Held
3.58MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$1.65 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$752,9180.03% of portfolio
-
Black Rock Inc. New York, NY333KShares$576,3850.0% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$467,1000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX184KShares$317,9560.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $86.1M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...